BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 14766261)

  • 21. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leiomyosarcoma of the uterus: a clinicopathological report of two cases and review of literature.
    Omoniyi-Esan GO; Badmos KB; Adeyemi AB; Rotimi O
    Afr J Med Med Sci; 2008 Sep; 37(3):285-8. PubMed ID: 18982823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility-sparing surgery in uterine leiomyosarcoma.
    Lissoni A; Cormio G; Bonazzi C; Perego P; Lomonico S; Gabriele A; Bratina G
    Gynecol Oncol; 1998 Sep; 70(3):348-50. PubMed ID: 9790786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leiomyosarcoma: a 45-year review at Charity Hospital, New Orleans.
    Hill MA; Mera R; Levine EA
    Am Surg; 1998 Jan; 64(1):53-60; discussion 60-1. PubMed ID: 9457038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
    Hardman MP; Roman JJ; Burnett AF; Santin AD
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):518-20. PubMed ID: 17666649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
    Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
    Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base.
    Straughn JM; Numnum TM; Kilgore LC; Partridge EE; Phillips JL; Markman M; Thomas GM; Burke TW;
    Gynecol Oncol; 2005 Dec; 99(3):530-5. PubMed ID: 16198401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between different postoperative treatment modalities of uterine carcinosarcoma.
    Menczer J; Levy T; Piura B; Chetrit A; Altaras M; Meirovitz M; Glezerman M; Fishman A
    Gynecol Oncol; 2005 Apr; 97(1):166-70. PubMed ID: 15790453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Uterine leiomyosarcomas: a surprising pathology. Review of the literature. Six case reports].
    Durand-Réville M; Dufour P; Vinatier D; Martin de Lassalle E; Lucot JP; Monnier JC; Lecomte-Houcke M; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):710-5. PubMed ID: 8991905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: a retrospective analysis and literature review.
    Chura JC; Marushin R; Boyd A; Ghebre R; Geller MA; Argenta PA
    Gynecol Oncol; 2007 Oct; 107(1):79-85. PubMed ID: 17588647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factors related to recurrence of choriocarcinoma and evaluation of treatment outcomes].
    Sun Y; Xiang Y; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):329-32. PubMed ID: 16762190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
    Hensley ML
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review.
    Thomas M; Mariani A; Wright JD; Madarek EO; Powell MA; Mutch DG; Podratz KC; Dowdy SC
    Gynecol Oncol; 2008 Feb; 108(2):293-7. PubMed ID: 18096208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.